Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors
International Journal of Drug Delivery Technology · 16.11.2026 · 16 (80s)
DOI: 10.25258/ijddt.16.80s.93 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.11.2026. Verfasst von Devakamma Lakumalla und 5 weiteren Autor:innen.
Abstract (Originalsprache)
The colchicine-binding site of tubulin represents an attractive target for the development of microtubuledisrupting anticancer agents. In the present study, a focused series of chalcone-hydrazone derivatives (3a–3j) was designed and investigated using an integrated in silico approach combining molecular property assessment, molecular docking, and ligand-based quantitative structure–activity relationship (QSAR) analysis. The designed derivatives incorporated different para-substituents on the benzylidene ring to examine their influence on tubulin binding and predicted antiproliferative activity. Molecular docking against the colchicine-binding site of human α/β-tubulin (PDB ID: 1SA0) showed favorable binding profiles across the series, with docking scores ranging from −9.1 to −10.8 kcal/mol. Compound 3c, bearing a para-nitro substituent, exhibited the most favorable docking score (−10.8 kcal/mol) and established multiple interactions within the binding pocket, including hydrogenbonding interactions involving Asn258 and Gln247 and additional electrostatic complementarity with Lys254. QSAR analysis further provided favorable activity estimates for the investigated derivatives against MCF-7 and A549 cell lines. Compound 3c showed the lowest estimated IC₅₀ values of 0.8 µM and 1.2 µM, respectively, followed by compound 3j with estimated IC₅₀ values of 1.0 µM and 1.5 µM. Correlation analysis between docking affinity and QSAR-derived pIC₅₀ values showed R² values of 0.808 for MCF-7 and 0.814 for A549 cells. Structure–activity relationship analysis indicated that electron-withdrawing para-substituents generally favored the computational binding and activity profiles of the chalcone-hydrazone scaffold. Overall, compounds 3c and 3j were identified as promising computational leads for further experimental synthesis and biological evaluation as potential tubulin-targeting anticancer agents.
Zitieren
APA
Lakumalla, D., Dasgupta, R. K., Alam, S., Nath, J., Fatima, S. J., & Veerabhadrappa, K. V. (2026). Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors. International Journal of Drug Delivery Technology, 16(80s). https://doi.org/10.25258/ijddt.16.80s.93
Vancouver
Lakumalla D, Dasgupta RK, Alam S, Nath J, Fatima SJ, Veerabhadrappa KV. Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors. International Journal of Drug Delivery Technology. 2026;16(80s). doi:10.25258/ijddt.16.80s.93
BibTeX
@article{Lakumalla2026,
author = {Lakumalla, Devakamma and Dasgupta, Ramesh Kumari and Alam, Shahjalal and Nath, Junmoni and Fatima, Syeda Jabeen and Veerabhadrappa, Kasturi Vishwanathasetty},
title = {Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {80s},
doi = {10.25258/ijddt.16.80s.93}
}
EUVIMED